Status:
UNKNOWN
Broad Band Emission LED Phototherapy Source Versus Narrow Band
Lead Sponsor:
Erebouni Medical Center
Conditions:
Neonatal Hyperbilirubinemia
Jaundice, Neonatal
Eligibility:
All Genders
24-14 years
Phase:
NA
Brief Summary
Phototherapy is the most frequently used treatment in neonatology when serum bilirubin levels exceed physiological limits. Light-emitting diodes (LEDs) are become routinely used for phototherapy in ne...
Eligibility Criteria
Inclusion
- non-haemolytic hyperbilirubinaemia, but otherwise healthy, indications for phototherapy based on NICE criteria, gestational age ≥33 weeks, birth weight ≥1800 g, postnatal age \>24 hrs and ≤14 days
Exclusion
- hemolytic jaundice, major congenital animalities and history of phototherapy. Infants with indication of intensive treatment double phototherapy were not included.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05257369
Start Date
January 1 2022
End Date
December 1 2022
Last Update
February 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erebouni Medical Centre, NICU
Yerevan, Armenia